BioLineRx Reports Third Quarter 2019 Financial Results and Provides Corporate Update
Go back to BioLineRx Reports Third Quarter 2019 Financial Results and Provides Corporate Update| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.48 -0.01 (0.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.49 | 52 Week High | $1.63 | |||
| Open | $2.53 | 52 Week Low | $0.71 | |||
| Day High | $2.58 | P/E | N/A | |||
| Day Low | $2.45 | EPS | $0.00 | |||
| Volume | 16,713 | |||||
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.48 -0.01 (0.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.49 | 52 Week High | $1.63 | |||
| Open | $2.53 | 52 Week Low | $0.71 | |||
| Day High | $2.58 | P/E | N/A | |||
| Day Low | $2.45 | EPS | $0.00 | |||
| Volume | 16,713 | |||||

